• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性内分泌腺瘤病2A突变激活ret原癌基因的机制。

Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations.

作者信息

Asai N, Iwashita T, Matsuyama M, Takahashi M

机构信息

Department of Pathology, Nagoya University School of Medicine, Japan.

出版信息

Mol Cell Biol. 1995 Mar;15(3):1613-9. doi: 10.1128/MCB.15.3.1613.

DOI:10.1128/MCB.15.3.1613
PMID:7532281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC230385/
Abstract

Transforming activity of the c-ret proto-oncogene with multiple endocrine neoplasia (MEN) 2A mutations was investigated by transfection of NIH 3T3 cells. Mutant c-ret genes driven by the simian virus 40 or cytomegalovirus promoter induced transformation with high efficiencies. The 170-kDa Ret protein present on the cell surface of transformed cells was highly phosphorylated on tyrosine and formed disulfide-linked homodimers. This result indicated that MEN 2A mutations induced ligand-independent dimerization of the c-Ret protein on the cell surface, leading to activation of its intrinsic tyrosine kinase. In addition to the MEN 2A mutations, we further introduced a mutation (lysine for asparaginic acid at codon 300 [D300K]) in a putative Ca(2+)-binding site of the cadherin-like domain. When c-ret cDNA with both MEN 2A and D300K mutations was transfected into NIH 3T3 cells, transforming activity drastically decreased. Western blot (immunoblot) analysis revealed that very little of the 170-kDa Ret protein with the D300K mutation was expressed in transfectants while expression of the 150-kDa Ret protein retained in the endoplasmic reticulum was not affected. This result also demonstrated that transport of the Ret protein to the plasma membrane is required for its transforming activity.

摘要

通过转染NIH 3T3细胞,研究了具有多发性内分泌腺瘤(MEN)2A突变的c-ret原癌基因的转化活性。由猿猴病毒40或巨细胞病毒启动子驱动的突变c-ret基因能高效诱导细胞转化。转化细胞表面存在的170 kDa Ret蛋白在酪氨酸上高度磷酸化,并形成二硫键连接的同型二聚体。这一结果表明,MEN 2A突变诱导细胞表面c-Ret蛋白发生非配体依赖性二聚化,从而激活其内在酪氨酸激酶。除了MEN 2A突变外,我们还在钙黏蛋白样结构域的一个假定钙结合位点引入了一个突变(第300位密码子天冬酰胺突变为赖氨酸[D300K])。当将同时具有MEN 2A和D300K突变的c-ret cDNA转染到NIH 3T3细胞中时,转化活性急剧下降。蛋白质免疫印迹分析显示,转染细胞中几乎不表达带有D300K突变的170 kDa Ret蛋白,而保留在内质网中的150 kDa Ret蛋白的表达不受影响。这一结果还表明,Ret蛋白转运到质膜对于其转化活性是必需的。

相似文献

1
Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations.多发性内分泌腺瘤病2A突变激活ret原癌基因的机制。
Mol Cell Biol. 1995 Mar;15(3):1613-9. doi: 10.1128/MCB.15.3.1613.
2
Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation.鉴定对于携带MEN2A或MEN2B突变的原癌基因ret的转化活性至关重要的酪氨酸残基。
Oncogene. 1996 Feb 1;12(3):481-7.
3
Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells.Ret原癌基因通过IRS-2/PI 3激酶/PKB和SHC/Grb-2依赖性途径进行信号转导:对NIH3T3细胞转化活性的潜在影响。
Mol Cell Endocrinol. 2000 Sep 25;167(1-2):69-76. doi: 10.1016/s0303-7207(00)00283-5.
4
Molecular mechanisms of development of multiple endocrine neoplasia 2 by RET mutations.RET 突变导致多发性内分泌腺瘤 2 型发生发展的分子机制。
J Intern Med. 1998 Jun;243(6):509-13.
5
Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.带有半胱氨酸突变的Ret的生物学特性与2A型多发性内分泌肿瘤、家族性甲状腺髓样癌及先天性巨结肠症表型相关。
Cancer Res. 1997 Jul 15;57(14):2870-2.
6
Repair by Src kinase of function-impaired RET with multiple endocrine neoplasia type 2A mutation with substitutions of tyrosines in the COOH-terminal kinase domain for phenylalanine.Src激酶对功能受损的、具有2A型多发性内分泌肿瘤突变(COOH末端激酶结构域中的酪氨酸被苯丙氨酸取代)的RET进行修复。
Cancer Res. 2002 Apr 15;62(8):2414-22.
7
A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with shc adaptor proteins.MEN2A-Ret和MEN2B-Ret中酪氨酸1062位点的突变会损害它们的转化活性以及与shc衔接蛋白的结合。
J Biol Chem. 1996 Jul 26;271(30):17644-9. doi: 10.1074/jbc.271.30.17644.
8
Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B.MEN2A和MEN2B的种系突变使RET作为主要转化基因被激活。
Science. 1995 Jan 20;267(5196):381-3. doi: 10.1126/science.7824936.
9
Characterization of Ret-Shc-Grb2 complex induced by GDNF, MEN 2A, and MEN 2B mutations.由胶质细胞源性神经营养因子(GDNF)、多发性内分泌肿瘤2A(MEN 2A)和多发性内分泌肿瘤2B(MEN 2B)突变诱导的Ret-Shc-Grb2复合物的特征
Biochem Biophys Res Commun. 1997 Aug 28;237(3):747-51. doi: 10.1006/bbrc.1997.7225.
10
Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.表达具有2A型多发性内分泌肿瘤突变的RET原癌基因的转基因小鼠中的组织特异性致癌作用。
Cancer Res. 2000 Sep 15;60(18):5254-60.

引用本文的文献

1
Characteristics of RET gene mutations in Vietnamese medullary thyroid carcinoma patients: a single-center analysis.越南甲状腺髓样癌患者RET基因突变特征:单中心分析
J Pathol Transl Med. 2025 Mar;59(2):125-132. doi: 10.4132/jptm.2025.01.18. Epub 2025 Mar 14.
2
Thyroid C-Cell Biology and Oncogenic Transformation.甲状腺C细胞生物学与致癌转化
Recent Results Cancer Res. 2025;223:51-91. doi: 10.1007/978-3-031-80396-3_3.
3
Targeting the RET tyrosine kinase in neuroblastoma: A review and application of a novel selective drug design strategy.针对神经母细胞瘤中的 RET 酪氨酸激酶:一种新型选择性药物设计策略的综述与应用。
Biochem Pharmacol. 2023 Oct;216:115751. doi: 10.1016/j.bcp.2023.115751. Epub 2023 Aug 16.
4
Medullary Thyroid Cancer: Updates and Challenges.甲状腺髓样癌:更新与挑战。
Endocr Rev. 2023 Sep 15;44(5):934-946. doi: 10.1210/endrev/bnad013.
5
Progress and challenges in RET-targeted cancer therapy.RET 靶向癌症治疗的进展与挑战。
Front Med. 2023 Apr;17(2):207-219. doi: 10.1007/s11684-023-0985-y. Epub 2023 May 3.
6
RET Proto-Oncogene-Not Such an Obvious Starting Point in Cancer Therapy.RET原癌基因——并非癌症治疗中一个显而易见的起点。
Cancers (Basel). 2022 Oct 27;14(21):5298. doi: 10.3390/cancers14215298.
7
A RET::GRB2 fusion in pheochromocytoma defies the classic paradigm of RET oncogenic fusions.在嗜铬细胞瘤中发现的 RET::GRB2 融合打破了经典的 RET 致癌融合范例。
Cell Rep Med. 2022 Jul 19;3(7):100686. doi: 10.1016/j.xcrm.2022.100686.
8
RET kinase alterations in targeted cancer therapy.靶向癌症治疗中的RET激酶改变
Cancer Drug Resist. 2020 May 11;3(3):472-481. doi: 10.20517/cdr.2020.15. eCollection 2020.
9
The gene encodes RET protein, which triggers intracellular signaling pathways for enteric neurogenesis, and mutation results in Hirschsprung's disease.该基因编码RET蛋白,RET蛋白可触发肠道神经发生的细胞内信号通路,而该基因突变会导致先天性巨结肠症。
AIMS Neurosci. 2022 Mar 16;9(1):128-149. doi: 10.3934/Neuroscience.2022008. eCollection 2022.
10
RET receptor signaling: Function in development, metabolic disease, and cancer.RET 受体信号转导:在发育、代谢疾病和癌症中的功能。
Proc Jpn Acad Ser B Phys Biol Sci. 2022;98(3):112-125. doi: 10.2183/pjab.98.008.

本文引用的文献

1
cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily.小鼠原癌基因ret的cDNA克隆及其与钙黏蛋白超家族的序列相似性。
Oncogene. 1993 Apr;8(4):1087-91.
2
Characterization of the ret proto-oncogene products expressed in mouse L cells.在小鼠L细胞中表达的原癌基因ret产物的特性分析。
Oncogene. 1993 Nov;8(11):2925-9.
3
Motifs of cadherin- and fibronectin type III-related sequences and evolution of the receptor-type-protein tyrosine kinases: sequence similarity between proto-oncogene ret and cadherin family.钙黏蛋白和纤连蛋白III型相关序列基序与受体型蛋白酪氨酸激酶的进化:原癌基因ret与钙黏蛋白家族之间的序列相似性
Mol Biol Evol. 1993 May;10(3):539-51. doi: 10.1093/oxfordjournals.molbev.a040033.
4
Expression of the c-ret proto-oncogene during mouse embryogenesis.c-ret原癌基因在小鼠胚胎发育过程中的表达。
Development. 1993 Dec;119(4):1005-17. doi: 10.1242/dev.119.4.1005.
5
Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret.缺乏酪氨酸激酶受体Ret的小鼠的肾脏和肠神经系统缺陷。
Nature. 1994 Jan 27;367(6461):380-3. doi: 10.1038/367380a0.
6
Mutations of the RET proto-oncogene in Hirschsprung's disease.先天性巨结肠症中RET原癌基因的突变
Nature. 1994 Jan 27;367(6461):378-80. doi: 10.1038/367378a0.
7
Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease.影响先天性巨结肠症中RET原癌基因酪氨酸激酶结构域的点突变。
Nature. 1994 Jan 27;367(6461):377-8. doi: 10.1038/367377a0.
8
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.RET原癌基因的突变与2A型多发性内分泌腺瘤病和家族性甲状腺髓样癌相关。
Hum Mol Genet. 1993 Jul;2(7):851-6. doi: 10.1093/hmg/2.7.851.
9
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.2A型多发性内分泌腺瘤病中RET原癌基因的种系突变。
Nature. 1993 Jun 3;363(6428):458-60. doi: 10.1038/363458a0.
10
Developmental expression of the RET protooncogene.
Cell Growth Differ. 1994 Mar;5(3):305-11.